The determination of common disease indicators is a cornerstone of modern preventive medicine, providing quantitative measurement of clinical biomarkers such as blood glucose, blood lipids, liver enzymes, and renal function markers for the early detection and long-term management of prevalent conditions like diabetes, dyslipidemia, and chronic kidney disease. This technical article explains the specimen types, tested parameters, analytical methods, quality standards, and typical applications used by accredited third-party laboratories and clinical laboratories performing these determinations.
Technical Overview
The determination of common disease indicators refers to the systematic quantitative and qualitative measurement of biochemical, hematological, and immunological markers that reflect the onset, progression, and control of frequently occurring diseases. These conditions typically include diabetes mellitus, dyslipidemia and atherosclerotic cardiovascular risk, chronic liver disease, chronic kidney disease, thyroid dysfunction, anemia, gout and hyperuricemia, and acute or chronic inflammation.
These determinations are performed on automated clinical chemistry analyzers, chemiluminescence immunoassay platforms, and hematology analyzers, with results interpreted against validated reference intervals and clinical decision limits. Analytical reliability depends on control of the total testing process: pre-analytical sample handling, method selection, calibration traceability to certified reference materials, internal quality control, and participation in external quality assessment schemes.
Laboratories performing this work are generally required to operate under ISO 15189, which specifies competence and quality requirements for medical laboratories. In vitro diagnostic instruments and reagents must conform to applicable product standards, such as the GB/T 29791 series for in vitro diagnostic medical devices and ISO 15197 for blood glucose self-monitoring systems. Accredited third-party laboratories provide an important supplement to hospital laboratories, particularly for large-scale health screening and occupational health programs.
Testing Samples
Serum
Serum separated from clotted venous blood collected in plain or gel-separator tubes is the primary specimen for clinical chemistry panels, covering glucose, lipids, liver enzymes, renal markers, and uric acid. Serum should be separated from the clot within two hours of collection to prevent glycolytic degradation of glucose and cellular leakage of enzymes.
Plasma
EDTA-anticoagulated plasma is required for glycated hemoglobin (HbA1c) and most molecular or cellular analyses, while fluoride and oxalate anticoagulation is preferred for glucose when sample processing is delayed, since fluoride inhibits glycolysis. Lithium heparin plasma is widely accepted by chemistry platforms and reduces turnaround time.
Whole Blood
Venous or capillary whole blood is used for point-of-care glucose testing, rapid hemoglobin measurement, and near-patient inflammation markers. Thorough mixing with anticoagulant is essential to prevent micro-clotting, which can cause erroneous cell counts and analyzer blockages.
Urine
Random midstream urine supports routine urinalysis, including protein, glucose, and ketone screening. First-morning urine is preferred for the albumin-to-creatinine ratio (ACR), a key early marker of diabetic nephropathy, while timed 24-hour collection may be required for quantitative protein and uric acid excretion studies.
Testing Items
Testing panels are organized by organ system and metabolic pathway. Typical indicator groups include the following:
- Glucose metabolism: fasting plasma glucose, 2-hour post-load glucose during oral glucose tolerance testing, HbA1c, insulin, and C-peptide
- Lipid metabolism: total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A1, apolipoprotein B, and lipoprotein(a)
- Liver function: alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total protein, albumin, total and direct bilirubin, and cholinesterase
- Renal function: creatinine, blood urea nitrogen, uric acid, cystatin C, and the estimated glomerular filtration rate (eGFR)
- Thyroid function: thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), and thyroid autoantibodies
- Hematology and anemia markers: complete blood count, hemoglobin, hematocrit, mean corpuscular volume, serum iron, ferritin, transferrin saturation, vitamin B12, and folate
- Inflammation and infection markers: C-reactive protein (CRP), high-sensitivity CRP, procalcitonin, erythrocyte sedimentation rate, and white blood cell differential
- Pancreatic and other enzymes: serum amylase, lipase, lactate dehydrogenase, and creatine kinase
- Electrolytes and minerals: sodium, potassium, chloride, calcium, phosphorus, and magnesium
Reference intervals are established or verified by the performing laboratory according to demographic factors such as age, sex, and, where relevant, pregnancy status, in line with ISO 15189 requirements.
Testing Methods
Spectrophotometric and Enzymatic Assays
Most chemistry indicators are measured by UV-visible spectrophotometry using enzyme-coupled colorimetric reactions. Representative methods include the hexokinase method for glucose, the cholesterol oxidase and peroxidase (CHOD-PAP) method for cholesterol, the glycerol phosphate oxidase method for triglycerides, the uricase method for uric acid, the urease and glutamate dehydrogenase method for urea, and enzymatic or compensated Jaffe methods for creatinine.
Electrochemical and Ion-Selective Electrode Methods
Electrolytes such as sodium, potassium, chloride, and ionized calcium are determined by ion-selective electrodes on integrated chemistry analyzers. Amperometric enzyme electrodes are the basis of point-of-care glucose meters, which must meet the accuracy criteria defined in ISO 15197.
Immunoassay Techniques
Protein and hormone markers are quantified by immunoassay. Chemiluminescence immunoassay (CLIA) is the dominant platform for thyroid hormones and tumor-adjacent markers, while immunoturbidimetry and nephelometry are used for CRP, apolipoproteins, immunoglobulins, and urinary microalbumin. Enzyme-linked immunosorbent assay (ELISA) remains common for high-throughput serological screening.
Chromatographic and Mass Spectrometric Methods
HbA1c is measured by ion-exchange high-performance liquid chromatography (HPLC), which is traceable to the reference method, or by boronate affinity chromatography and enzymatic assays. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) serves as a reference-level technique for steroid hormones, vitamin D metabolites, and confirmation of critical values.
Hematological Cell Analysis
Complete blood counts are performed by automated analyzers using electrical impedance, laser light scatter, and flow cytometric principles, with result verification by microscopy review when instrument flags indicate abnormal cell populations.
Quality Control and Standardization
Valid determination requires documented pre-analytical control (fasting status, tube type, transport temperature, hemolysis and lipemia indices), instrument calibration against traceable materials, daily internal quality control evaluated with Levey-Jennings charts and Westgard multi-rules, and regular participation in external quality assessment and proficiency testing programs. These controls form the core of ISO 15189 accreditation.
Applications
Preventive Health Screening
Annual and periodic health examinations rely on combined panels of glucose, lipids, liver and renal markers, uric acid, and complete blood counts to detect asymptomatic metabolic abnormalities and enable early intervention before clinical disease develops.
Chronic Disease Management
For patients with established diabetes, dyslipidemia, hypertension, or chronic kidney disease, serial determination of HbA1c, lipid ratios, creatinine, eGFR, and urinary albumin guides pharmacological treatment adjustment and evaluates long-term control and target-organ protection.
Clinical Diagnosis and Monitoring
Dynamic measurement of liver enzymes, pancreatic enzymes, thyroid hormones, and inflammation markers supports differential diagnosis, severity grading, and monitoring of treatment response in both outpatient and inpatient settings, including emergency triage of acute conditions.
Public Health and Occupational Programs
Accredited third-party laboratories support large-scale community screening programs, employee wellness initiatives, pre-employment and occupational exposure surveillance, and epidemiological studies that require standardized, high-throughput biomarker determination across large populations.
FAQ
Is fasting required before sample collection?
Fasting for 8 to 12 hours is required for accurate lipid panels and fasting glucose determination, and water intake is permitted. HbA1c, thyroid function, and complete blood counts generally do not require fasting, but laboratories should always confirm specific requirements when panels are combined.
How are results interpreted against reference intervals?
A result is compared with the reference interval established or verified by the performing laboratory for the relevant population. For some markers, such as LDL cholesterol or HbA1c, clinical decision limits defined by international guidelines are applied instead of, or in addition to, population reference intervals.
What is the typical turnaround time?
Routine chemistry and hematology panels are commonly reported within 24 hours of sample receipt. Immunoassay panels may take one to three working days, and specialized chromatographic or mass spectrometric confirmations may require additional time depending on batch scheduling.
What factors can interfere with the determination?
Common interferences include hemolysis, icterus, lipemia, delayed sample separation, recent high-fat meals, vigorous exercise before collection, and certain medications. Laboratories assess sample integrity using hemolysis and lipemia indices and may request recollection when interference invalidates a result.
How can result reliability be assured?
Reliability is assured through ISO 15189-accredited quality management systems, calibration traceability to certified reference materials, daily internal quality control, external quality assessment participation, and documented competency of analysts, together with validated analytical methods meeting defined performance specifications for precision and trueness.